Unresectable Retiform Hemangioendothelioma Treated with External Beam Radiation Therapy and Chemotherapy: A Case Report and Review of the Literature
Open Access
- 26 September 2010
- journal article
- review article
- Published by Hindawi Limited in Sarcoma
- Vol. 2010, 1-3
Abstract
Retiform hemangioendothelioma (RH) is an infrequently encountered vascular neoplasm of intermediate or borderline malignancy. Treatment of RH is controversial. We present a case of a 44-year-old Asian male presenting with an unresectable RH of the pelvis. The patient was treated with concurrent low-dose Cisplatin and External beam Radiation (4140cGy in 180cGy per fraction). This is the first report of a clinical complete response and a long-term local control of this rare tumor. This has significant clinical implication, since it gives the first evidence of treatment of this rare tumor using concurrent low-dose chemotherapy and radiation.Keywords
This publication has 13 references indexed in Scilit:
- Retiform Hemangioendotheliomas Usually do not Express D2-40 and VEGFR-3The American Journal of Dermatopathology, 2008
- Retiform hemangioendothelioma: a case report and review of the literatureJournal of Cutaneous Pathology, 2005
- Retiform hemangioendothelioma presenting as bruise‐like plaque in an adult womanInternational Journal of Dermatology, 2004
- Epithelioid and retiform hemangioendothelioma of the skull bone--report of four cases.2003
- Retiform hemangioendotheliomaInternational Journal of Dermatology, 2000
- Retiform hemangioendothelioma: Another tumor associated with human herpesvirus type 8?Journal of the American Academy of Dermatology, 2000
- Retiformes HämangioendotheliomDer Pathologe, 1997
- Retiform hemangioendothelioma. A new case in a child with diffuse endovascular papillary endothelial proliferationJournal of Cutaneous Pathology, 1997
- Multiple Retiform HemangioendotheliomasThe American Journal of Dermatopathology, 1996
- Retiform HemangioendotheliomaAmerican Journal of Surgical Pathology, 1994